Development and evaluation of a decision aid for HPV vaccination among adults aged 27–45 years old in the United States

被引:0
|
作者
Wheldon, Christopher W. [1 ]
Grace, Jessica [2 ,6 ]
Zimet, Gregory [3 ]
Daley, Ellen M. [4 ]
Akpan, Idara N. [2 ]
Alkhatib, Sarah A. [2 ]
Thompson, Erika L. [2 ,5 ]
机构
[1] Department of Social & Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B. Moore Ave., Philadelphia,PA,19122, United States
[2] Department of Population and Community Health, School of Public Health, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth,TX,76107, United States
[3] Department of Population and Community Health, School of Public Health, Pediatrics, Indiana University School of Medicine and Zimet Research Consulting LLC, 1625 Sturbridge Road, Indianapolis,IN,46260, United States
[4] College of Public Health, University of South Florida, Tampa, FL, 13201 Bruce B. Downs Blvd, MDC 56, Tampa,FL,33612, United States
[5] Department of Quantitative and Qualitative Health Sciences, University of Texas School of Public Health San Antonio, University of Texas Health Science Center at San Antonio, 8403 Floyd Curl Drive, San Antonio,TX,78229, United States
[6] Department of Social Work, College of Health and Public Service, University of North Texas, 410 Ave. C, Denton,TX,76201, United States
关键词
D O I
10.1016/j.compbiomed.2024.109557
中图分类号
学科分类号
摘要
Objective: To design, develop, and field test the HPV Decide decision tool to facilitate shared clinical decision-making recommendation for mid-adult HPV vaccination. Methods: The ‘HPV Decide’ online tool was developed through a 6-step process, involving community and provider advisory boards, usability testing with 10 end users (unvaccinated adults aged 27–45), field testing interviews with another 10, and interviews with 18 healthcare providers. The process incorporated both inductive and deductive qualitative data analyses. Results: The logic model, based on the Ottawa Decision Support Framework, highlighted the importance of objective knowledge and managing decisional conflict. Iterative modifications were informed by the advisory boards, alpha testing, and usability testing. Field testing showed utility to end users, highlighting the straightforward design, and lack of medical jargon. Many expressed a desire to access the tool before doctor appointments, emphasizing its value in a healthcare context and in partnership with providers. Lastly, healthcare provider feedback highlighted information quality, structure, acceptability, and future implementation. Discussion: While users recognized the tool's information quality and user-centric design, full evaluation focused on changes in informed decision making and clinic-based implementation are needed. Practical value: The HPV Decide decision tool demonstrates promise in supporting informed decisions about HPV vaccination among mid-adults. © 2024 Elsevier Ltd
引用
收藏
相关论文
共 50 条
  • [41] THE ESTIMATED IMPACT OF HPV VACCINATION COVERAGE ON LIFETIME CERVICAL CANCER CASES AMONG GIRLS CURRENTLY AGED 12 YEARS AND YOUNGER IN THE UNITED STATES
    Chesson, Harrell
    Markowitz, Lauri
    Dunne, Eileen
    SEXUALLY TRANSMITTED DISEASES, 2014, 41 : S52 - S52
  • [42] Percentage of Adults Aged ≥45 Years Who Use a Hearing Aid, by Sex and Age Group - National Health Interview Survey, United States, 2021
    不详
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (06): : 163 - 163
  • [43] Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment
    Patterson, Brandon J.
    Myers, Kelley
    Stewart, Alexandra
    Mange, Brennan
    Hillson, Eric M.
    Poulos, Christine
    EXPERT REVIEW OF VACCINES, 2021, 20 (06) : 729 - 741
  • [44] Hepatitis B vaccination coverage among adults aged ≥ 18 years traveling to a country of high or intermediate endemicity, United States, 2015
    Lu, Peng-jun
    O'Halloran, Alissa C.
    Williams, Walter W.
    Nelson, Noele P.
    VACCINE, 2018, 36 (18) : 2471 - 2479
  • [45] Incomplete Human Papillomavirus (HPV) Vaccination among Individuals Ages 27-45 in the United States: A Mixed-Effects Analysis of Individual and Contextual Factors
    Adekanmbi, Victor
    Guo, Fangjian
    Hsu, Christine D.
    Shan, Yong
    Kuo, Yong-Fang
    Berenson, Abbey B.
    JOURNAL OF WOMENS HEALTH, 2023, 32 (11) : A22 - A23
  • [46] Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18-26 and 27-45 years in the United States: A cross-sectional study
    Arevalo, Mariana
    Brownstein, Naomi C.
    Whiting, Junmin
    Vadaparampil, Susan T.
    Head, Katharine J.
    Meade, Cathy D.
    Islam, Jessica Y.
    Kasting, Monica L.
    Gwede, Clement K.
    Barrios-Monroy, Veronica
    Christy, Shannon M.
    CANCER, 2023, 129 (08) : 1237 - 1252
  • [47] Depression and anxiety associated with cardiovascular disease among persons aged 45 years and older in 38 states of the United States
    Fan, Amy Z.
    Strine, Tara W.
    Jiles, Ruth
    Mokdad, Ali H.
    PREVENTIVE MEDICINE, 2008, 46 (05) : 445 - 450
  • [48] Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007
    Lu, Peng-jun
    Jain, Nidhi
    Cohn, Amanda C.
    VACCINE, 2010, 28 (11) : 2350 - 2355
  • [49] Public health and aging:: Influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years -: United States, 2002 (Reprinted from MMWR, vol 52, pg 987-992, 2003)
    Wortley, PM
    Jain, N
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2656 - 2657
  • [50] Cardiovascular Hospitalizations and Mortality Among Young Adults Aged 25 to 64 Years in the United States
    Henry, Chantal M.
    Oseran, Andrew S.
    Zheng, ZhaoNian
    Dong, Huaying
    Wadhera, Rishi K.
    CIRCULATION, 2023, 148